Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2025

Revenue growth above 20%Net loss reportedNegative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.1%Reaction day

₹950.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+4.0% vs market

Diversified Commercial Services peers, median of 66sector+0.0%+4.1% vs sector

On the reaction day the stock moved 4.0 pts more than Nifty Microcap 250 and 4.1 pts more than its Diversified Commercial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.1+0.1+4.0+0.0+4.1

Next day

+9.1-0.2+9.3-0.1+9.2

+9.3+0.3+9.0-0.5+9.8

+7.3+0.9+6.4+0.0+7.3

+8.4+0.8+7.6+0.1+8.3

+8.4+2.2+6.2+1.2+7.1

+7.9+3.4+4.5+1.2+6.7

15d

+5.8-0.8+6.6-0.9+6.6

+1.0+2.9-1.9-1.9+3.0

+2.6+0.8+1.8-6.4+9.1

—+0.0—-7.0—

UpDownMarket · Nifty Microcap 250Sector · Diversified Commercial Services peers, median of 66Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Eyantra Ventures (formerly Punit Commercials) reported audited FY25 results with standalone revenue from operations nearly doubling to ₹2,759.27 lakhs (vs ₹1,405.78 lakhs in FY24, +96% YoY). Standalone net profit surged to ₹166.39 lakhs (vs ₹74.45 lakhs, +123% YoY), lifting EPS to ₹8.98 from ₹4.46. On a consolidated basis, FY25 revenue grew to ₹3,270.29 lakhs but net profit fell to ₹75.07 lakhs (vs ₹106.49 lakhs) dragged by a ₹38.84 lakh share of loss from associate Neuro and Spine Associates. Q4 FY25 standalone profit dropped sharply to ₹5.06 lakhs and the company posted a consolidated Q4 loss of ₹61.52 lakhs. Both standalone and consolidated operating cash flows were negative (-₹35.07 and -₹113.05 lakhs), with growth funded mainly by a ₹15 crore preferential issue in January 2025.

Likely market impact

Strong top-line and standalone earnings growth is positive, but the consolidated profit decline, Q4 standalone profit drop, and negative operating cash flows are concerns for shareholders. The auditor issued an unmodified opinion, providing some comfort on reporting quality.